Narihito Seki

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Benign Prostatic Hyperplasia

Patient Satisfaction

Top Venues

Lower urinary tract symptoms

This page only lists publications with an associated author ORCID identifier.

Publications

Narihito Seki, Hiroyuki Masaoka, Yoohyun Song, Takashi Dejima, Yoshiaki Sato, Shotaro Maeda
Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL). Lower urinary tract symptoms 16 (4) (2024)
Narihito Seki, Hiroyuki Masaoka, Yoohyun Song, Takashi Dejima, Yoshiaki Sato, Shotaro Maeda
Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL). Lower urinary tract symptoms 16 (4) (2024)
Tatsunori Okada, Mikifumi Koura, Ryota Sumikawa, Hiroyuki Masaoka, Yoohyun Song, Takashi Dejima, Narihito Seki
A prospective, single-center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180-W GreenLight XPS laser, a 300-W diode laser, and a 200-W thulium laser for the treatment of benign prostatic hyperplasia. Lower urinary tract symptoms 14 (5) (2022)
Takeshi Kobayashi, Narihito Seki, Yoo H Song, Takashi Dejima
GreenLight HPS laser 120 W vs diode laser 300 W vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single-center, randomized clinical trial. Lower urinary tract symptoms 13 (1) (2020)
Tomonori Yamanishi, Hirotaka Asakura, Narihito Seki, Shoji Tokunaga
A 52-week multicenter randomized controlled study of the efficacy and safety of add-on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study). Lower urinary tract symptoms 11 (3) (2018)